Type 2 Diabetes Trial, Not Yet Recruiting NCT07116902 Sponsor: University of California, San Francisco Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Not Yet Recruiting

NCT07116902
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 10 and 21 years old.
  • People who have been diagnosed with type 2 diabetes, based on a doctor's diagnosis or medical records.
  • People who have had type 2 diabetes for at least 3 months.
  • People whose HbA1c blood sugar level is 7% or above (this is a measure of average blood sugar over time).
  • People whose diabetes medications have been stable, with no changes and no change in long-acting insulin dose of more than 20% in the two weeks before joining the study.
  • People who are able to wear a continuous glucose monitor (a small sensor that tracks blood sugar levels) for a total of 6 weeks during the study.
  • People who speak English or Spanish.
  • People who are willing to follow the study's recommendations and procedures.
  • People who are willing and able to sign the consent form themselves, or who have a parent or guardian willing and able to sign it on their behalf.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have tested positive for certain antibodies linked to a different type of diabetes (such as GAD-65, insulin, IA-2, ICA 512, or ZnT8 antibodies).
  • People who are planning to have weight-loss (bariatric) surgery during the study period.
  • People who are expected to use steroid medications taken throughout the body (such as prednisone) during the study period.
  • People who are unable to stop taking more than 500mg per day of Vitamin C during the study, as high doses of Vitamin C can interfere with the sensor readings.
  • People who have a condition or health issue that, in the study doctor's opinion, could affect their safety or the reliability of the study data (confirm with trial site).
  • People who have a condition or health issue that, in the study doctor's opinion, is likely to cause repeated hospital stays or significant medication changes during the study (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in HbA1C

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov